semaglutide bulk cost

FDA Proposes to Exclude Semaglutide, Tirzepatide, Liraglutide From 503B Bulks List — Photo by Tara Winstead on Pexels

Semaglutide vs 503B - How Cost Swings 40%

The FDA’s decision to pull semaglutide and tirzepatide from the 503B bulks list will raise bulk purchase costs by roughly 40%, forcing clinics to shift sourcing strategies. This change impacts wholesale pricing, pharmacy workflows, and patient out-of-pocket expenses across the United States. Medical Disclaimer: This article is for informational